PharmaCyte Biotech to Attend 53rd Annual Meeting of the American Society of Clinical Oncology
May 31, 2017 13:34 pm UTC| Business
LAGUNA HILLS, Calif., May 31, 2017 -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes using its signature live-cell...
PharmaCyte Biotech to Attend 53rd Annual Meeting of the American Society of Clinical Oncology
May 31, 2017 13:34 pm UTC| Business
LAGUNA HILLS, Calif., May 31, 2017 -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes using its signature live-cell...
PharmaCyte Biotech to Attend 53rd Annual Meeting of the American Society of Clinical Oncology
May 31, 2017 13:34 pm UTC| Business
LAGUNA HILLS, Calif., May 31, 2017 -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes using its signature live-cell...
PharmaCyte Biotech to Attend 53rd Annual Meeting of the American Society of Clinical Oncology
May 31, 2017 13:34 pm UTC| Business
LAGUNA HILLS, Calif., May 31, 2017 -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes using its signature live-cell...
PharmaCyte Biotech to Attend 53rd Annual Meeting of the American Society of Clinical Oncology
May 31, 2017 13:34 pm UTC| Business
LAGUNA HILLS, Calif., May 31, 2017 -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes using its signature live-cell...
PharmaCyte Biotech to Attend 53rd Annual Meeting of the American Society of Clinical Oncology
May 31, 2017 13:34 pm UTC| Business
LAGUNA HILLS, Calif., May 31, 2017 -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes using its signature live-cell...
PharmaCyte Biotech to Attend 53rd Annual Meeting of the American Society of Clinical Oncology
May 31, 2017 13:34 pm UTC| Business
LAGUNA HILLS, Calif., May 31, 2017 -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes using its signature live-cell...
US–India Trade Turbocharge: Stocks Poised to Ride the Export Wave